Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
Mar. 31, 2018	Mar. 31, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ (10,183)	$ 98,942
Adjustments to reconcile net income (loss) to net cash from operating activities:
Depreciation and amortization	37,834	43,269
Foreign currency (gains) losses	1,220	(6,619)
(Gain) on the sale of real estate investments	(19)	(85,188)
(Gain) loss on derivative instruments	(351)	12
Changes in assets and liabilities:
Change in other assets	(3,351)	(5,431)
Change in tenant and other receivables	4,208	12,931
Change in deferred leasing costs	(3,869)	(17,578)
Change in accounts payable and accrued expenses	(21,780)	3,636
Change in other liabilities	(692)	(4,621)
Change in due to affiliates	(3,655)	(10,534)
Net cash (used in) from operating activities	(638)	28,819
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from the sale of real estate investments	0	299,242
Capital expenditures at operating properties and developments	(11,795)	(8,376)
Investments in real estate loans receivable	0	(158)
Proceeds from collection of real estate loans receivable	0	56
Net cash (used in) from investing activities	(11,795)	290,764
CASH FLOWS FROM FINANCING ACTIVITIES:
Contribution from noncontrolling interest	70	0
Redemption of common shares	(32,904)	(19,855)
Payments of issuer costs	(47)	(18)
Distributions paid to stockholders and noncontrolling interests	(310,204)	(30,301)
Redemption of CPEC	0	(52,552)
Proceeds from notes payable	109,000	38,000
Payments on notes payable	(29,844)	(162,701)
Change in security deposit liability	(14)	(74)
Deferred financing costs paid	(9)	(163)
Net cash used in financing activities	(263,952)	(227,664)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	1,183	1,599
Net change in cash, cash equivalents, and restricted cash	(275,202)	93,518
Cash, cash equivalents, and restricted cash, beginning of period	418,210	156,724
Cash, cash equivalents, and restricted cash, end of period	$ 143,008	$ 250,242

The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Differs from the amount on the income statement due to the amortization of deferred financing costs and out of market leases that are recorded elsewhere on the cash flow statement.

No definition available.